M
MindBio Therapeutics Corp
OTC:MBQIF
MindBio Therapeutics Corp
OTC:MBQIF
Price:
0.0451
USD
Market Closed
Market Cap:
$92k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MindBio Therapeutics Corp
OTC:MBQIF
|
CA |
|
T
|
Thai Coating Industrial PCL
SET:TCOAT
|
TH |
|
R
|
Royalties Inc
CNSX:RI
|
CA |
|
Vicinity Centres
ASX:VCX
|
AU |
|
Republic Technologies Inc
OTC:DOCKF
|
CA |
|
N
|
Neogen Corp
F:NG2
|
US |
|
T
|
Tao Heung Holdings Ltd
F:BVI
|
HK |
|
BioMark Diagnostics Inc
OTC:BMKDF
|
CA |
|
American Pacific Mining Corp
F:1QC
|
CA |
|
PowerBank Corp
NASDAQ:PBK
|
CA |
|
Rural Funds Group
F:J19
|
AU |
|
M
|
Morien Resources Corp
OTC:APMCF
|
CA |
|
infinitii ai inc
F:Y31
|
CA |
Intrinsic Value
Not Available for MBQIF
There is not enough data to reliably calculate the intrinsic value for MindBio Therapeutics Corp.
Do our valuations actually work? See backtest results .
Alternatives to MBQIF
Fundamental Analysis
What MindBio Therapeutics Does
Mindbio Therapeutics Corp. engages in developing psychedelic medicines to treat medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2023-05-05. The firm is focused on creating novel and emerging treatments for mental health conditions and is conducting lysergic acid diethylamide (LSD)-microdosing human clinical trials.
- Headquarters
- Canada CA
- IPO date
- May 5, 2023
Financials
Efficiency
Earnings Waterfall
MindBio Therapeutics Corp
MindBio Therapeutics Corp
